Abbott Labs obtained clearance from the Meals and Drug Administration for an app that pairs with its steady glucose monitor (CGM).
The iPhone app would let individuals get glucose readings immediately on their cellphone with out utilizing a reader. Customers can scan a sensor constructed into the Freestyle Libre 2 to get their present glucose studying and developments. They’ll additionally share glucose readings and real-time alarms with caregivers. The app is cleared for use by each adults and kids, ages 4 and up.
Abbott obtained clearance for the Freestyle Libre 2 final 12 months. The latest CGM was designed to be paired with different gadgets, similar to its app, in addition to good insulin pens, such because the one developed by Bigfoot Biomedical. It transmits blood glucose information each minute utilizing a Bluetooth sign, and likewise offers customers the power to set an alarm if blood glucose ranges are too excessive or too low.
That mentioned, Abbott isn’t the one firm trying to make a linked CGM on this extremely aggressive market. San Diego-based Dexcom not too long ago received FDA clearance to permit different digital well being apps, similar to Livongo and Garmin, to connect with its information via APIs. The corporate plans to launch its latest CGM, the G7, later this 12 months.
Photograph credit score: Zhuyufang, Getty Photographs